Perrigo Net Income 2010-2024 | PRGO

Perrigo net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Perrigo Annual Net Income
(Millions of US $)
2024 $-172
2023 $-13
2022 $-141
2021 $-69
2020 $-163
2019 $146
2018 $131
2017 $120
2016 $-4,013
2015 $43
2015 $136
2014 $233
2013 $442
2012 $402
2011 $339
2010 $224
2009 $146
Perrigo Quarterly Net Income
(Millions of US $)
2024-12-31 $-44
2024-09-30 $-21
2024-06-30 $-108
2024-03-31 $2
2023-12-31 $-32
2023-09-30 $14
2023-06-30 $8
2023-03-31 $-3
2022-12-31 $-24
2022-09-30 $-49
2022-06-30 $-65
2022-03-31 $-2
2021-12-31 $10
2021-09-30 $-59
2021-06-30 $-58
2021-03-31 $38
2020-12-31 $-175
2020-09-30 $-155
2020-06-30 $61
2020-03-31 $106
2019-12-31 $-19
2019-09-30 $92
2019-06-30 $9
2019-03-31 $64
2018-12-31 $82
2018-09-30 $-68
2018-06-30 $36
2018-03-31 $81
2017-12-31 $73
2017-09-30 $45
2017-06-30 $-70
2017-03-31 $72
2016-12-31 $-1,359
2016-09-30 $-1,590
2016-06-30 $-534
2016-03-31 $-529
2015-12-31 $-174
2015-09-30 $261
2015-06-30 $-22
2015-03-31 $-22
2014-12-31 $70
2014-09-30 $96
2014-06-30
2014-03-31 $48
2013-12-31 $-86
2013-09-30 $111
2013-06-30
2013-03-31 $112
2012-12-31 $106
2012-09-30 $106
2012-06-30
2012-03-31 $116
2011-12-31 $100
2011-09-30 $70
2011-06-30
2011-03-31 $89
2010-12-31 $90
2010-09-30 $74
2010-06-30
2010-03-31 $62
2009-12-31 $61
2009-09-30 $52
2009-06-30
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.510B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.763B 27.35
Boston Scientific (BSX) United States $152.152B 38.10
Stryker (SYK) United States $142.721B 30.67
EssilorLuxottica (ESLOY) France $133.556B 0.00
Medtronic (MDT) Ireland $108.708B 15.87
Lonza Group Ag (LZAGY) Switzerland $51.613B 0.00
Haleon (HLN) United Kingdom $45.796B 26.03
ResMed (RMD) United States $34.691B 26.06
GE HealthCare Technologies (GEHC) United States $32.200B 15.29
Agilent Technologies (A) United States $30.677B 20.26
Terumo (TRUMY) Japan $28.397B 0.00
Koninklijke Philips (PHG) Netherlands $23.827B 17.01
Zimmer Biomet Holdings (ZBH) United States $20.388B 12.88
Insulet (PODD) United States $17.717B 75.76
Baxter (BAX) United States $15.988B 11.50
Smith & Nephew SNATS (SNN) United Kingdom $12.272B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.145B 17.57
Bio-Rad Laboratories (BIO) United States $6.837B 23.67
Prestige Consumer Healthcare (PBH) United States $4.024B 19.20
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.362B 28.64
Haemonetics (HAE) United States $3.166B 14.90
Envista Holdings (NVST) United States $2.725B 22.03
GN Store Nord (GNNDY) Denmark $2.260B 18.72
LeMaitre Vascular (LMAT) United States $2.050B 46.77
QuidelOrtho (QDEL) United States $1.875B 15.70
AtriCure (ATRC) United States $1.480B 0.00
Green Thumb Industries (GTBIF) United States $1.401B 22.00
Kestra Medical Technologies (KMTS) United States $1.235B 0.00
AdaptHealth (AHCO) United States $1.148B 11.05
BioLife Solutions (BLFS) United States $1.145B 0.00
Neogen (NEOG) United States $1.096B 14.03
InMode (INMD) Israel $0.981B 8.98
Phibro Animal Health (PAHC) United States $0.754B 11.56
Evolus (EOLS) United States $0.735B 0.00
Curaleaf Holdings (CURLF) Canada $0.713B 0.00
Capricor Therapeutics (CAPR) United States $0.580B 0.00
CeriBell (CBLL) United States $0.577B 0.00
Owens & Minor (OMI) United States $0.545B 4.64
Valneva SE (VALN) France $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Cresco Labs (CRLBF) United States $0.479B 0.00
Omeros (OMER) United States $0.427B 0.00
Surmodics (SRDX) United States $0.400B 0.00
SNDL (SNDL) Canada $0.392B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.343B 14.86
Verano Holdings (VRNOF) United States $0.323B 0.00
Sanara MedTech (SMTI) United States $0.284B 0.00
Viemed Healthcare (VMD) United States $0.279B 25.25
Aurora Cannabis (ACB) Canada $0.261B 46.40
Canopy Growth (CGC) Canada $0.254B 0.00
Cerus (CERS) United States $0.252B 0.00
ZimVie (ZIMV) United States $0.252B 15.10
OraSure Technologies (OSUR) United States $0.232B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
Quanterix (QTRX) United States $0.223B 0.00
High Tide (HITI) Canada $0.195B 0.00
Biote (BTMD) United States $0.182B 4.16
Utah Medical Products (UTMD) United States $0.170B 13.69
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
Brainsway (BWAY) Israel $0.164B 51.00
Organigram Global (OGI) Canada $0.146B 0.00
Jin Medical (ZJYL) China $0.142B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
TerrAscend (TSNDF) Canada $0.128B 0.00
Agape ATP (ATPC) $0.115B 0.00
Exagen (XGN) United States $0.112B 0.00
MacroGenics (MGNX) United States $0.109B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.082B 0.00
Veru (VERU) United States $0.079B 0.00
Fonar (FONR) United States $0.078B 10.91
InterCure (INCR) Israel $0.072B 0.00
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Zynex (ZYXI) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Apyx Medical (APYX) United States $0.039B 0.00
Safety Shot (SHOT) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.037B 54.00
United-Guardian (UG) United States $0.036B 11.14
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00